Cite
Miyagi S, Watanabe T, Hara Y, et al. A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis. Cancer Sci. 2021;112(12):5088-5099doi: 10.1111/cas.15152.
Miyagi, S., Watanabe, T., Hara, Y., Arata, M., Uddin, M. K., Mantoku, K., Sago, K., Yanagi, Y., Suzuki, T., Masud, H. M. A. A., Kawada, J. I., Nakamura, S., Miyake, Y., Sato, Y., Murata, T., & Kimura, H. (2021). A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis. Cancer science, 112(12), 5088-5099. https://doi.org/10.1111/cas.15152
Miyagi, Shouhei, et al. "A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis." Cancer science vol. 112,12 (2021): 5088-5099. doi: https://doi.org/10.1111/cas.15152
Miyagi S, Watanabe T, Hara Y, Arata M, Uddin MK, Mantoku K, Sago K, Yanagi Y, Suzuki T, Masud HMAA, Kawada JI, Nakamura S, Miyake Y, Sato Y, Murata T, Kimura H. A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis. Cancer Sci. 2021 Dec;112(12):5088-5099. doi: 10.1111/cas.15152. Epub 2021 Oct 11. PMID: 34609775.
Copy
Download .nbib